Team
Accel-Heal Technologies Limited was established in 2020 by a team of specialists with over 130 years’ combined experience. Each member of the team is passionate about what they do and together, they work to develop and deliver products that help to transform the lives of patients with painful and hard-to-heal wounds.
Meet the people behind Accel-Heal.
OUR FRENCH TEAM
Olivier Guedon
Directeur Général
Olivier a plus de 20 ans d'expérience dans le domaine des ventes et du marketing lié au traitement des plaies. Il a participé au lancement de la thérapie par électrostimulation dès 2009 et a contribué avec son équipe à mettre en avant cette technologie. Connaissant bien ce type de dispositif et les attentes des patients et des soignants, il a rejoint Accel-Heal pour mettre en avant un dispositif efficace et simple à utiliser. Il a également été responsable du marketing chez Smith & Nephew pour les dispositifs de technologies actives. Scientifique de formation, mais aussi diplômé en commerce et marketing (AUDENCIA), il a toujours été très attaché à lancer de nouvelles technologies auprès des professionnels de la santé afin de réduire la complexité du traitement des plaies et d'améliorer l'accès à des produits plus efficaces.
Christophe Palluault
Responsable Grands Comptes
Christophe a 20 ans d'expérience dans la vente de dispositifs médicaux, dont 9 ans spécifiquement dans le traitement des plaies chroniques et/ou douloureuses par électrostimulation. Il aime échanger avec le corps médical sur leurs pratiques et protocoles de traitement des plaies chroniques, ce qui est très enrichissant et lui permet de s'adapter au mieux à leurs besoins.
OUR UK TEAM
ANDY BOYES
CHIEF EXECUTIVE OFFICER
Andy has enjoyed a successful 32-year career at Smith & Nephew. During his time at the FTSE 100 medical technology business, Andy engaged in developing, manufacturing, marketing and selling medical devices in the Advanced Wound Management and Advanced Surgical Devices sectors. He has held a number of executive level roles across commercial, strategic and innovation functions. Andy is passionate about the wound care sector and helping to improve the lives of patients suffering with debilitating complex wounds and since leaving Smith & Nephew has provided Board level support and strategic direction in the sector.
ANDREW WILDMAN ACA
CHIEF FINANCIAL OFFICER
Andrew has over 25 years’ experience working in and advising start-up and early stage businesses from inception through to exit. Andrew brings experience of managing businesses through the growth phase, determining corporate strategy and development, establishing strong corporate governance and preparing businesses for a successful exit. A Chartered Accountant since 1994, Andrew cut his teeth at Deloitte and Ernst & Young. Andrew has seen first-hand the damage that non-healing wounds does to people and is fanatical about raising the profile of this silent epidemic and improving healing rates.
PAUL MCKENNA
COMMERCIAL DIRECTOR
Paul has over 25 years’ experience in wound management sales and marketing. He was previously responsible for leading global and regional marketing teams at Smith & Nephew, the FTSE 100 medical technology business. In the last 10 years he has been focussed on launching new technologies to health care professionals to help reduce complexity of wound care and improve access to more effective products. He maintains a fervent desire to support easier adoption of medical devices by health care practitioners to help them and their patients improve their outcomes.
JESSICA WOOTTEN
OPERATIONS DIRECTOR
Jessica has over 10 years’ experience as a regulatory professional, with a strong track record of success, overseeing the manufacturing, operations and regulatory compliance areas of the business. Jessica also plays an active role in a number of Supplier Work Groups, hosted by the Association of British HealthTech Industries.